Changes in the Genomic Spectrum of Actionable Alterations in HER2 Negative Metastatic Breast Cancer in Serial Cell Free DNA (cfDNA) Analysis

被引：0
|
作者：
Bar, Yael
Keenan, Jennifer C.
Ryan, Lianne
Juric, Dejan
Shin, Jennifer
Wander, Seth A.
Spring, Laura M.
Moy, Beverly
Ellisen, Leif
Isakoff, Steven J.
Bardia, Aditya
Vidula, Neelima
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P4-01-14
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-14
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.
    Olson, E. M.
    Flores, L. M.
    Najita, J. S.
    Curley, C.
    Jeong, J.
    Murray, K.
    Savoie, J. J.
    Winer, E. P.
    Krop, I. E.
    CANCER RESEARCH, 2011, 71
  • [32] Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
    Fernandez-Garcia, Daniel
    Hills, Allison
    Page, Karen
    Hastings, Robert K.
    Toghill, Bradley
    Goddard, Kate S.
    Ion, Charlotte
    Ogle, Olivia
    Boydell, Anna Rita
    Gleason, Kelly
    Rutherford, Mark
    Lim, Adrian
    Guttery, David S.
    Coombes, R. Charles
    Shaw, Jacqueline A.
    BREAST CANCER RESEARCH, 2019, 21 (01)
  • [33] Impact of HER2 low status on genomic signatures in triple negative breast cancer (TNBC)
    Taylor, Melissa
    Reddy, Shilpa
    Kumar, Prashanth Ashok
    Hariri, Dana
    Sokol, Ethan
    Sivakumar, Smruthy
    Quintanilha, Julia
    Pavlick, Dean
    Levy, Mia Alyce
    Ross, Jeffrey S.
    Lustberg, Maryam B.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Serial genomic analysis of circulating tumor cells and circulating tumor DNA in triplenegative and HER2-positive advanced, metastatic breast cancer.
    Lee, Ji Eun
    Shin, Kabsoo
    Joe, Seung Yeon
    Lee, Hayoon
    Park, Junghoon
    Jeon, Byung Hee
    Lee, Ahwon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Broad, hybrid capture-based next generation sequencing identified actionable genomic alterations in HER2-negative breast cancer.
    Hou, Helei
    Liu, Dong
    Zhou, Na
    Zhang, Jinping
    Zhang, Chuantao
    Sun, Mei
    Zhang, Xiaoping
    Wang, Zhe
    Yang, Xiaonan
    Li, Zhuokun
    Qian, Zhaoyang
    Wu, Renhua
    Zhu, Hongmei
    Wang, Rongjiao
    Liu, Xin
    Zhang, Xiaochun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Analysis of HER2 distribution concordance in breast cancer tissue by serial IHC staining
    Peng, G-R.
    Ye, C-H.
    Lee, J. Y. C.
    Hu, S.
    Yu, W-C.
    Lin, W-C.
    Yu, S-H.
    ANNALS OF ONCOLOGY, 2021, 32 : S374 - S374
  • [37] Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative,-Low, and-Positive Metastatic Breast Cancer
    Eisses, Bertha
    van Geel, Jasper J. L.
    Brouwers, Adrienne H.
    Bensch, Frederike
    Elias, Sjoerd G.
    Kuip, Evelien J. M.
    Jager, Agnes
    van der Vegt, Bert
    Lub-de Hooge, Marjolijn N.
    Emmering, Jasper
    Arens, Anne I. J.
    Zwezerijnen, Gerben J. C.
    Vugts, Danielle J.
    van Oordyt, C. Willemien Menke-van der Houven
    de Vries, Elisabeth G. E.
    Schroder, Carolina P.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (10) : 1540 - 1547
  • [38] Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine hospital
    Arenos, C. C.
    San Juan, M.
    Lim, S.
    Lominoque, A.
    Reveldez, I.
    Sison-DImaano, A.
    Pangandaman, N.
    Tatoy, V.
    Uy, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1390 - S1390
  • [39] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
  • [40] Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape
    Redfern, Andrew
    Burslem, Katie
    Woodward, Natasha
    Beith, Jane
    Mccarthy, Nicole
    De Boer, Richard
    Bell, Richard
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 19 - 31
12345